Effectiveness of Biologic Agents Among Hispanic Patients With Metastatic Colorectal Cancer
[ad_1] Background: Randomized clinical trials have defined the survival advantage with the addition of biologic drugs to chemotherapy in patients with metastatic colorectal cancer (mCRC). Under representation of Hispanics contributes […]



















